BINDING OF [26-H-3]-EPI-BRYOSTATIN-4 TO PROTEIN-KINASE-C

被引:14
作者
LEWIN, NE
PETTIT, GR
KAMANO, Y
BLUMBERG, PM
机构
[1] NCI,CELLULAR CARCINOGENESIS & TUMOR PROMOT LAB,BETHESDA,MD 20892
[2] ARIZONA STATE UNIV,CANC RES INST,TEMPE,AZ 85287
来源
CANCER COMMUNICATIONS | 1991年 / 3卷 / 03期
关键词
D O I
10.3727/095535491820873506
中图分类号
学科分类号
摘要
Structure activity analysis of protein kinase C modulators may permit design of selective inhibitors of this important regulatory enzyme. Modeling suggests that the C-26 secondary hydroxyl of bryostatin is homologous to the C-20 primary hydroxyl of phorbol or the C-3 primary hydroxyl of sn-1,2-diacylglycerols (Wender, P. A.; Cribbs, C. M.; Koehler, K. F.; Sharkey, N. A.; Herald, C. L.; Kamano, Y.; Pettit, G. R.; Blumberg, P. M. Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C. Proc. Natl. Acad. Sci. USA 85:7197-7201; 1980). We have characterized the binding activity to protein kinase C of the epimer of bryostatin 4 with the configuration at C-26 inverted from R (natural configuration) to S. The K(d) of [26-H-3]-epi-bryostatin 4 for protein kinase C reconstituted in the presence of phosphatidylserine was 13 +/- 2 nM. [26-H-3]-Epi-bryostatin 4 thus retained moderate absolute affinity. Relatively, however, inversion at the chiral center at C-26 caused a dramatic decrease in binding affinity. Binding of [26-H-3]-epi-bryostatin 4 was competitively inhibited by phorbol 12, 13-diacetate, as expected for ligands that interact at the same binding site.
引用
收藏
页码:67 / 70
页数:4
相关论文
共 24 条
[11]  
IRIE K, 1985, INT J CANCER, V36, P485
[12]   A RECEPTOR MODEL FOR TUMOR PROMOTERS - RATIONAL SUPERPOSITION OF TELEOCIDINS AND PHORBOL ESTERS [J].
ITAI, A ;
KATO, Y ;
TOMIOKA, N ;
IITAKA, Y ;
ENDO, Y ;
HASEGAWA, M ;
SHUDO, K ;
FUJIKI, H ;
SAKAI, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (11) :3688-3692
[13]   COMPUTER-ASSISTED MOLECULAR MODELING OF TUMOR PROMOTERS - RATIONALE FOR THE ACTIVITY OF PHORBOL ESTERS, TELEOCIDIN-B, AND APLYSIATOXIN [J].
JEFFREY, AM ;
LISKAMP, RMJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (02) :241-245
[14]  
LELI U, 1990, MOL PHARMACOL, V37, P286
[15]   ABSOLUTE STEREOCHEMISTRIES OF THE APLYSIATOXINS AND OSCILLATOXIN-A [J].
MOORE, RE ;
BLACKMAN, AJ ;
CHEUK, CE ;
MYNDERSE, JS ;
MATSUMOTO, GK ;
CLARDY, J ;
WOODARD, RW ;
CRAIG, JC .
JOURNAL OF ORGANIC CHEMISTRY, 1984, 49 (13) :2484-2489
[16]   STRUCTURAL BASIS OF PROTEIN KINASE-C ACTIVATION BY TUMOR PROMOTERS [J].
NAKAMURA, H ;
KISHI, Y ;
PAJARES, MA ;
RANDO, RR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9672-9676
[17]  
NISHIZUKA Y, 1989, CANCER, V63, P1892, DOI 10.1002/1097-0142(19890515)63:10<1892::AID-CNCR2820631005>3.0.CO
[18]  
2-Z
[19]   ANTINEOPLASTIC AGENTS .119. ISOLATION AND STRUCTURE OF BRYOSTATIN-10 AND BRYOSTATIN-11 [J].
PETTIT, GR ;
KAMANO, Y ;
HERALD, CL .
JOURNAL OF ORGANIC CHEMISTRY, 1987, 52 (13) :2848-2854
[20]   ANTI-NEOPLASTIC AGENTS .86. ISOLATION AND STRUCTURE OF BRYOSTATIN-1 [J].
PETTIT, GR ;
HERALD, CL ;
DOUBEK, DL ;
HERALD, DL ;
ARNOLD, E ;
CLARDY, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (24) :6846-6848